Kenvue Inc.

KVUE

US49177J1025

Personal Products

Market Closed - Nyse Other stock markets 04:00:02 2024-12-11 pm EST			5-day change	1st Jan Change
22.22 ^USD	-2.29%		-4.06%	+3.20%

Dec. 11	HSBC Adjusts Price Target on Kenvue to $23 From $21, Keeps Hold Rating	MT
Dec. 09	RBC Upgrades Kenvue to Outperform From Sector Perform, Price Target is $24	MT

Kenvue Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024

November 07, 2024 at 06:45 am EST

Kenvue Inc. reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported sales was USD 3,899 million compared to USD 3,915 million a year ago. Net income was USD 383 million compared to USD 438 million a year ago. Basic earnings per share from continuing operations was USD 0.2 compared to USD 0.23 a year ago. Diluted earnings per share from continuing operations was USD 0.2 compared to USD 0.23 a year ago.
For the nine months, sales was USD 11,793 million compared to USD 11,778 million a year ago. Net income was USD 737 million compared to USD 1,337 million a year ago. Basic earnings per share from continuing operations was USD 0.38 compared to USD 0.73 a year ago. Diluted earnings per share from continuing operations was USD 0.38 compared to USD 0.73 a year ago.

Latest news about Kenvue Inc.

HSBC Adjusts Price Target on Kenvue to $23 From $21, Keeps Hold Rating	Dec. 11	MT
RBC Upgrades Kenvue to Outperform From Sector Perform, Price Target is $24	Dec. 09	MT
Kenvue Inc. Presents at Morgan Stanley Global Consumer & Retail Conference, Dec-04-2024 11:45 AM	Dec. 04
BNP Paribas Exane Lifts Price Target on Kenvue to $24 From $22	Nov. 20	MT
Tranche Update on Kenvue Inc.'s Equity Buyback Plan announced on October 26, 2023.	Nov. 07	CI
Kenvue Inc., Q3 2024 Earnings Call, Nov 07, 2024	Nov. 07
Stock Futures Rise Amid Trump Victory as Traders Focus on Fed Decision; Asia, Europe Rise	Nov. 07	MT
Kenvue's Q3 Adjusted Earnings, Net Sales Decline	Nov. 07	MT
Earnings Flash (KVUE) KENVUE Posts Q3 EPS $0.28	Nov. 07	MT
Earnings Flash (KVUE) KENVUE Posts Q3 Revenue $3.90B	Nov. 07	MT
Kenvue misses quarterly sales estimates on sluggish skincare sales	Nov. 07	RE
Kenvue Inc. Provides Earnings Guidance for the Year 2024	Nov. 07	CI
Kenvue Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	Nov. 07	CI
Kenvue Likely to See 'Muted' Q3 Amid Skin Health & Beauty Challenges, RBC Says	Nov. 05	MT
Kenvue Canada Inc., a Division of Kenvue Inc., Expands Ontario Manufacturing Facility to Boost Production of Over-The-Counter Medicines	Nov. 04	CI
Starboard Value Reportedly Buys Stake in Kenvue	Oct. 23	MT
Starboard says Kenvue's skin health segment is weighing on performance	Oct. 22	RE
Dow, S&P 500 Retreat From Record Highs Ahead of Major Earnings	Oct. 21	MT
Dow, S&P 500 Retreat From Record Highs Ahead of Week's Major Earnings	Oct. 21	MT
Equities Mostly Fall Intraday as Markets Await This Week's Major Earnings	Oct. 21	MT
Sector Update: Consumer Stocks Mixed Pre-Bell Monday	Oct. 21	MT
Sector Update: Consumer	Oct. 21	MT
Starboard Value Reportedly Buys Stake in Kenvue	Oct. 21	MT
Starboard Value Sets its Sights on Kenvue	Oct. 21	CI
Starboard takes stake in consumer products maker Kenvue, sources say	Oct. 20	RE

Chart Kenvue Inc.

Duration

Period

KVUE: Dynamic Chart

Company Profile

Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (41,8%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (29.9%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (28.3%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49.3%), Europe-Middle East-Africa (21.9%), Asia-Pacific (20.1%) and Latin America (8.7%).

Employees

22,000

Sector

Personal Products

Calendar

2025-02-05 - Q4 2024 Earnings Release (Projected)

More about the company